Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis

This study has been withdrawn prior to enrollment.
(Principle Investigator has left the University.)
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
University of Utah
ClinicalTrials.gov Identifier:
NCT00026468
First received: November 9, 2001
Last updated: July 23, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: July 1999
  Primary Completion Date: July 1999 (Final data collection date for primary outcome measure)